CROSSWALK PSC35170ARecalls & reported problems
Asahi Intecc CO., Ltd. · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04547327133630), received between Sep 18, 2025 and Sep 19, 2025 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Break1
- Material Split, Cut or Torn1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 19, 2025Break; Break
THE CROSSWALK BROKE INTO 2 PIECES BY OVER TORQUING THE CATHETER WHILE TRYING TO CROSS THE RIGHT SFA. THE PHYSICIAN SAID HE OVER TORQUED THE CATHETER. THE DEVICE WAS ABLE TO BE REMOVED BY PULLING THE SHEATH OUT WHILE THE CROSSWALK WAS STILL IN THE SHEATH. THE PHYSICIAN THEN PULLED EVERYTHING BACK IN THE SHEATH AND ALL COMPONENTS WERE REMOVED INCLUDING BOTH PIECES OF THE CROSSWALK. THERE WAS NO HARM TO THE PATIENT. EVERYTHING WAS REMOVED FROM THE BODY AND PRESSURE WAS HELD ON THE RADIAL ARTERY FOR ACCESS CLOSURE. PATIENT DID FINE. PATIENT DID FINE. PATIENT WAS DISCHARGED IN NORMAL FASHION.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23096854 ↗MalfunctionSep 18, 2025Material Split, Cut or Torn; Material Split, Cut or Torn
IT WAS REPORTED THAT AN ASAHI CROSSWALK SUPPORT CATHETER WAS USED FOR A PLAIN OLD BALLOON ANGIOPLASTY (POBA) TO CROSS A MODERATELY CALCIFIED CHRONIC TOTAL OCCLUSION (CTO) LESION IN THE RIGHT SUPERFICIAL FEMORAL ARTERY (SFA). AS EXCESSIVE TORQUE WAS APPLIED, THE SUBJECT CROSSWALK SUPPORT CATHETER WAS SEPARATED. AS THE SUPPORT CATHETER WAS LOCATED IN AN UNSPECIFIED CONCOMITANT SHEATH, THE PHYSICIAN PULL ALL OF THE DEVICES INCLUDING THE SEPARATED CROSSWALK SUPPORT CATHETER PIECES AND REMOVED EX SITU. THE PHYSICIAN COMMENTED THAT HE OVER-TORQUED THE CROSSWALK SUPPORT CATHETER. IT WAS INFORMED THAT THERE WAS NO HEALTH HAZARDS CAUSED BY THE EVENT, AND THE PATIENT WAS DISCHARGED. AS THE SCHEDULED PROCEDURE HAD BEEN HALTED JUST BEFORE THE REPORTED EVENT OCCURRED, ANOTHER PROCEDURE WAS SCHEDULED TO ACCESS FROM A DIFFERENT SITE AT A LATER DATE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23081154 ↗
Other Catheter, percutaneous devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page